93 related articles for article (PubMed ID: 28816390)
1. Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.
Ahram M; Mustafa E; Zaza R; Abu Hammad S; Alhudhud M; Bawadi R; Zihlif M
Cell Biol Int; 2017 Dec; 41(12):1345-1355. PubMed ID: 28816390
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
[TBL] [Abstract][Full Text] [Related]
4. The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells.
Ahram M; Mustafa E; Abu Hammad S; Alhudhud M; Bawadi R; Tahtamouni L; Khatib F; Zihlif M
Endocr Res; 2018 Aug; 43(3):203-214. PubMed ID: 29578828
[TBL] [Abstract][Full Text] [Related]
5. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
6. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
7. Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
Al-Othman N; Hammad H; Ahram M
Gene; 2018 Oct; 675():128-135. PubMed ID: 29964098
[TBL] [Abstract][Full Text] [Related]
8. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
Moore NL; Buchanan G; Harris JM; Selth LA; Bianco-Miotto T; Hanson AR; Birrell SN; Butler LM; Hickey TE; Tilley WD
Endocr Relat Cancer; 2012 Aug; 19(4):599-613. PubMed ID: 22719059
[TBL] [Abstract][Full Text] [Related]
9. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
10. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
11. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
Sheikholeslami A; Nabiuni M; Arefian E
Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
[TBL] [Abstract][Full Text] [Related]
12. The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior.
Leite KR; Morais DR; Florez MG; Reis ST; Iscaife A; Viana N; Moura CM; Silva IA; Katz BS; Pontes J; Nesrallah A; Srougi M
Urol Oncol; 2015 Jun; 33(6):267.e15-22. PubMed ID: 25920548
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
19. Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
Casaburi I; Cesario MG; Donà A; Rizza P; Aquila S; Avena P; Lanzino M; Pellegrino M; Vivacqua A; Tucci P; Morelli C; Andò S; Sisci D
Oncotarget; 2016 Mar; 7(11):12651-61. PubMed ID: 26862856
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
